http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110504017-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00778 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-037 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H30-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-508 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-5235 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H30-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-40 |
| filingDate | 2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110504017-B |
| titleOfInvention | Preparation and application method of tracer |
| abstract | The invention discloses a molecular imaging method for evaluating liver regeneration capacity after ALPPS operation. The method comprises the following steps: 1) making VX2 Rabbit liver cancer model 2) Rabbit VX2 liver cancer model ALPPS operation 3) 18 F-fluoromethylcholine (F 18 F‑methylcholine， 18 F-FCH). 4) 18 F-FCH PET/CT imaging and data processing. The invention is originally put forward to use for the first time 18 F-FCH PET/CT monitoring of the proliferative capacity of the residual liver, based on 18 The F-FCH has higher choline metabolism in the residual liver tissue, so that the increase of the cell membrane synthesis capacity is indirectly reflected, the regeneration capacity of the residual liver after the ALPPS operation is evaluated by a molecular imaging method, and an important new thought is provided for clinically selecting the optimal time for the second-phase operation of the ALPPS selection. |
| priorityDate | 2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.